https://www.zacks.com/stock/news/2208203/cardinal-health-cah-streamlines-operation-with-new-structure?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208203
Jan 10, 2024 - Cardinal Health's (CAH) new reporting structure is likely to streamline operations, providing better visibility of growth areas. At-home solutions and OptiFreight Logistics are possibly the key value creators.
zc:2181326639084336320
0
https://www.zacks.com/stock/news/2208088/here-s-why-investors-should-retain-integra-iart-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2208088
Jan 10, 2024 - Investors remain optimistic about Integra (IART) due to the positive outlook for its CSS segment.
zc:8054054381622052271
0
https://www.zacks.com/stock/news/2208083/medtronic-mdt-wins-ce-mark-for-minimed-780g-with-simplera-sync?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208083
Jan 10, 2024 - Medtronic (MDT) secures the CE Mark for the MiniMed 780G system with the disposable, all-in-one Simplera Sync CGM.
zc:7791624660071069328
0
https://www.zacks.com/stock/news/2207650/quest-diagnostics-dgx-to-boost-lab-services-with-new-buyout?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207650
Jan 09, 2024 - Quest Diagnostics' (DGX) recent acquisition seeks to increase accessibility to cutting-edge, high-caliber and reasonably priced laboratory services.
zc:-1517303758259171151
0
https://www.zacks.com/stock/news/2207629/here-s-why-you-should-retain-omnicell-omcl-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2207629
Jan 09, 2024 - Investors are optimistic about Omnicell (OMCL) owing to its strong Pharmacy model and geographical expansion.
zc:-2855787710108298094
0
https://www.zacks.com/stock/news/2207546/qiagen-qgen-gains-from-new-alliances-amid-fx-headwind?cid=CS-ZC-FT-analyst_blog|zer_report_update-2207546
Jan 09, 2024 - QIAGEN (QGEN) is progressing well with its testing menu expansion strategy, which is driving the company's growth.
zc:7025992600839157637
0
https://www.zacks.com/stock/news/2207539/senestech-s-snes-new-partnership-to-broaden-evolve-s-scope?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207539
Jan 09, 2024 - The collaboration with a global leader in irrigation solutions for sustainable agriculture aligns with SenesTech's (SNES) target to introduce Evolve to a broader audience.
zc:5205676130457072264
0
https://www.zacks.com/stock/news/2207160/here-s-why-investors-should-retain-abbott-abt-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2207160
Jan 08, 2024 - Investors are optimistic about Abbott (ABT) led by solid prospects in the Diagnostic business and raised guidance.
zc:-4308153346418575906
0
https://www.zacks.com/stock/news/2207066/asensus-surgical-asxc-completes-surgeon-lab-for-luna?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2207066
Jan 08, 2024 - Asensus Surgical's (ASXC) latest Surgeon Lab helps it move closer to a finalized LUNA product.
zc:-7981378164980051053
0
https://www.zacks.com/stock/news/2206372/boston-scientific-bsx-rides-on-global-growth-amid-macro-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2206372
Jan 05, 2024 - Within APAC, Boston Scientific (BSX) is registering strong growth in Japan and China.
zc:5234357664999751236
0